Prolonged molecular remission after autologous stem cell transplantation in relapsed acute promyelocytic leukemia.
Six patients with relapsed acute promyelocytic leukemia (APL) received autologous stem cell transplantation (ASCT) in second (n=5) or fourth (n=1) molecular remission with a molecularly negative graft. After a median follow-up of 33 months from ASCT, 5 patients are alive in molecular remission and one died 27 months after autograft from refractory relapse.
Ferrara
Felicetto
F
Palmieri
Salvatore
S
Annunziata
Mario
M
Pocali
Barbara
B
Viola
Assunta
A
Pane
Fabrizio
F
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000628:therapy*; D008297:Male; D012008:Recurrence; D012074:Remission Induction; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous